PVR and neoplasm: CD155 is another immune checkpoint protein, expressing on tumor cells and interacts with CD96, CD226, and T cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) on tumor-infiltrating lymphocytes to modulate the immune function in tumor immune microenvironment [6–8].